PDS Biotechnology (PDSB) announced it plans to fully enroll the VERSATILE-002 trial for PDS0101 in head and neck cancer after the Phase 2 study achieved its preliminary objective…
PDS Biotech to further advance mid-stage trial for head and neck cancer after early win